High ‐dose‐rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report

High ‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT. AbstractHigh ‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT.

Source: Clinical Case Reports - August 14, 2019 Category: General Medicine Authors: Yoshiaki Takagawa, Naoya Murakami, Shigenobu Suzuki, Fumihiko Matsumoto, Seiichi Yoshimoto, Jun Itami Tags: CASE REPORT Source Type: research